Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five each year, and children who survive repeated infections by gut pathogens in the early years of their life may suffer from lifelong health problems. This continuous rise in enteric infections among children is one of the major factors contributing to growth of the enteric disease testing market. Moreover, increasing launch of enteric disease testing products by key manufacturers is expected assist the growth of the market over the forecast period.
Key features of the study
• This report provides in-depth analysis of the Global Enteric Disease Testing market and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Enteric Disease Testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Enteric Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Enteric Disease Testing market
Market Segmentation
• By Disease Type
o E. coli Infection
o Salmonellosis
o Campylobacteriosis
o Rotavirus Infection
o Cryptosporidiosis
o Norovirus Infection
o Cholera
o C. difficile
o H. pylori
o Amebiasis
o Shigellosis
• By Regional Insights
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Argentina
 Mexico
 Rest of Latin America
o Europe
 Germany
 U.K.
 Spain
 France
 Italy
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC Countries
 Israel
 Rest of Middle East
o Africa
 South Africa
 North Africa
 Central Africa
• Key Players Insights
o Alere, Inc
o Becton Dickinson & Company
o Biomerica, Inc
o bioMerieux
o Bio-Rad, Cepheid
o Coris BioConcept
o DiaSorin
o Meridian Bioscience, Inc.
o Quest Diagnostics
o Trinity Biotech

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Disease Type
 Market Snippet, By Country
 Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Key Highlights
o Product launch
o PEST Analysis
o Technological Advancements
o Regulatory Scenario
o Mergers and Acquisitions
4. Global Enteric Disease Testing Market, By Disease Type, 2026 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2025, 2028, and 2033 (%)
 Y-o-Y Growth Analysis, 2017 – 2027
 Segment Trends
o E. coli Infection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Salmonellosis
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Campylobacteriosis
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Rotavirus Infection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Cryptosporidiosis
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Norovirus Infection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Cholera
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o C. difficile
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o H. pylori
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Amebiasis
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Shigellosis
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Enteric Disease Testing Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
 Y-o-Y Growth Analysis, For Regions, 2021-2033
o North America
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o U.S.
o Canada
o Latin America
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o Germany
o U.K.
o France
o Spain
o Italy
o Russia
o Rest of Europe
o Asia Pacific
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o China
o Japan
o India
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
 Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
 Market Size and Forecast, By Country, 2026-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
6. Competitive Landscape
o Company Profiles
 Alere, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Becton Dickinson & Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Biomerica, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 bioMerieux
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Bio-Rad
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Cepheid
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Coris BioConcept
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 DiaSorin
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Meridian Bioscience, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Quest Diagnostics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
 Trinity Biotech
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
7. Section
o References
o Research Methodology
o About us and Sales Contact